Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Vaes, Evelien"'
Autor:
Lacroix, Olivia, Couttenier, Alexandra, Vaes, Evelien, Cardwell, Chris R., De Schutter, Harlinde, Robert, Annie
Publikováno v:
Cancer Causes & Control, 2019 Apr 01. 30(4), 385-393.
Externí odkaz:
https://www.jstor.org/stable/48691260
Autor:
Couttenier, Alexandra, Lacroix, Olivia, Silversmit, Geert, Vaes, Evelien, De Schutter, Harlinde, Robert, Annie
Publikováno v:
In Cancer Epidemiology October 2019 62
Autor:
Lacroix, Olivia, Couttenier, Alexandra, Vaes, Evelien, Cardwell, Chris R., De Schutter, Harlinde, Robert, Annie
Publikováno v:
In Cancer Epidemiology April 2018 53:149-155
Autor:
Goossens, Mathijs C., De Brabander, Isabel, De Greve, Jacques, Vaes, Evelien, Van Ongeval, Chantal, Van Herck, Koen, Kellen, Eliane
Publikováno v:
European Journal of Cancer Prevention, 2017 Sep 01. 26(5), 396-403.
Externí odkaz:
https://www.jstor.org/stable/48504648
Publikováno v:
European Journal of Cancer Prevention, 2017 Sep 01. 26, 157-163.
Externí odkaz:
https://www.jstor.org/stable/48504542
Autor:
Babaei, Masoud, Balavarca, Yesilda, Jansen, Lina, Lemmens, Valery, van Erning, Felice N., van Eycken, Liesbet, Vaes, Evelien, Sjövall, Annika, Glimelius, Bengt, Ulrich, Cornelia M., Schrotz-King, Petra, Brenner, Hermann
Publikováno v:
International Journal of Cancer, 142(7), 1480-1489. Wiley-Liss Inc.
The advantage of adjuvant chemotherapy (ACT) for treating Stage III colon cancer patients is well established and widely accepted. However, many patients with Stage III colon cancer do not receive ACT. Moreover, there are controversies around the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dce87f3b0917fe16d1edd17f8d02fdbe
https://pure.eur.nl/en/publications/abefef8b-6aa5-440d-b7f4-b2aa66466a46
https://pure.eur.nl/en/publications/abefef8b-6aa5-440d-b7f4-b2aa66466a46
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vaes, Evelien1 evelien.vaes@biophys.mpg.de, Khan, Mona1 mona.khan@biophys.mpg.de, Mombaerts, Peter1,2 peter.mombaerts@biophys.mpg.de
Publikováno v:
BMC Bioinformatics. 2014, Vol. 15 Issue 1, p2-28. 27p. 1 Chart, 5 Graphs.
Autor:
Silversmit, Geert, Jegou, David, Vaes, Evelien, Van Hoof, Elke, Goetghebeur, Els, Van Eycken, Liesbet
Cumulative relative survival curves for many cancers reach a plateau several years after diagnosis, indicating that the cancer survivor group has reached "statistical" cure. Parametric mixture cure model analysis on grouped relative survival curves p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9c2286f06c8b28adb838d5fb6e8c7307
https://doi.org/10.1002/ijc.30532
https://doi.org/10.1002/ijc.30532
Autor:
Cardwell, Chris R., Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J., Brown, Chris, Vissers, Pauline A. J., O’Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G., van Herk-Sukel, Myrthe P. P., Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen
Publikováno v:
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, van Herk-Sukel, M P P, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer : a pooled analysis of European breast cancer cohorts ', Breast Cancer Research (Online), vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, van Herk-Sukel, M P P, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts ', Breast Cancer Research, vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, Herk-Sukel, M P P V, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer : A pooled analysis of European breast cancer cohorts ', Breast Cancer Research, vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, van Herk-Sukel, M P P, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer : a pooled analysis of European breast cancer cohorts ', Breast Cancer Research (Online Edition), vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Breast Cancer Research : BCR
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, van Herk-Sukel, M P P, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts ', Breast Cancer Research, vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, Herk-Sukel, M P P V, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer : A pooled analysis of European breast cancer cohorts ', Breast Cancer Research, vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Cardwell, C R, Pottegård, A, Vaes, E, Garmo, H, Murray, L J, Brown, C, Vissers, P A J, O'Rorke, M, Visvanathan, K, Cronin-Fenton, D, De Schutter, H, Lambe, M, Powe, D G, van Herk-Sukel, M P P, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, ' Propranolol and survival from breast cancer : a pooled analysis of European breast cancer cohorts ', Breast Cancer Research (Online Edition), vol. 18, no. 1, 119 . https://doi.org/10.1186/s13058-016-0782-5
Breast Cancer Research : BCR
BACKGROUND: Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether breast cancer patients who used propranolol, or other non-selective beta-blocke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::af684b7ca2898a5a5415756f2b09c994
https://findresearcher.sdu.dk:8443/ws/files/123648801/Propranolol_and_survival_from_breast_cancer.pdf
https://findresearcher.sdu.dk:8443/ws/files/123648801/Propranolol_and_survival_from_breast_cancer.pdf